Glycosphingolipid expression in acute nonlymphocytic leukemia: Common expression of shiga toxin and parvovirus B19 receptors on early myeloblasts

Blood

Volumn 101, Issue 2, 2003, Pages 711-721

  Cooling, Laura L W ^a   Zhang, De Sheng ^a   Naides, Stanley J ^a   Koerner, Theodore A W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; GLOBOTETRAOSYLCERAMIDE; GLOBOTRIAOSYLCERAMIDE; GLUCOSYLCERAMIDE; GLYCOSPHINGOLIPID; LACTOSYLCERAMIDE; PARAGLOBOSIDE; SHIGA TOXIN; UNCLASSIFIED DRUG; VIRUS RECEPTOR;

ACUTE NONLYMPHOCYTIC LEUKEMIA; ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CELL MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FAST ATOM BOMBARDMENT MASS SPECTROMETRY; GAS CHROMATOGRAPHY; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; MYELOBLAST; NUCLEAR MAGNETIC RESONANCE; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL;

EID: 0037438641     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-03-0718     Document Type: Article

References (99)

1. Stults CLM, Sweeley CC, Macher BA. Glycosphingolipids: structure, biological source and properties. Methods Enzymol. 1989;179:167-214.
2. Ichikawa S, Hirabayashi Y. Glucosylceramide synthase and glycosphingolipid synthesis. Trends Cell Biol. 1998;8:198-202.
3. Karlsson K-A. Animal glycosphingolipids as membrane attachment sites for bacteria. Annu Rev Biochem. 1989;53:309-350.
4. Kasahara K, Sanai Y. Possible roles of glycosphingolipids in lipid rafts. Biophys Chem. 1999;82:121-127.
5. Jarvis WD, Grant S, Kolesnick RN. Ceramide and the induction of apoptosis. Clin Cancer Res. 1996;2:1-6.
6. Hakomori SI, Igarashi Y. Gangliosides and glycosphingolipids as modulators of cell growth, adhesion and transmembrane signaling. Adv Lipid Res, 1993;25:147-162.
7. Hakomori S. Cancer-associated glycosphingolipid antigens: their structure, organization and function. Acta Anat. 1998;161:79-90.
8. Saito M. Bioctive gangliosides: differentiation inducers for hematopoietic cells and their mechanisms of action. Adv Lipid Res. 1993;25:303-327.
9. Sietsma H, Kamps WA, Dontje B, et al. Leukemia-induced bone marrow depression: effects of gangliosides on erythroid cell production. Int J Cancer. 1999;82:92-97.
10. Valentino LA, Ladisch S. Tumor gangliosides enhance α2β1 integrin-dependent platelet activation. Biochim Biophys Acta. 1996;1316:19-28.
11. Ferroni P, Lenti L, Guadagni F, et al. Possible involvement of tumour cell membrane gangliosides in platelet-tumour cell interactions. Eur J Cancer. 1995;31:79-84.
12. Ghislain J, Lingwood CA, Fish EN. Evidence for glycosphingolipid modification of the type 1 IFN receptor. J Immunol. 1994;153:3655-3663.
13. Naidenko OV, Koezuka Y, Kronenberg M. CD1-mediated antigen presentation of glycosphingolipids. Microbes Infect. 2000;2:621-631.
14. Lund-Johansen F, Olweus J, Horejsi V, et al. Activation of human phagocytes through carbohydrate antigens (CD15, sialyl-CD15, CDw17 and CDw65). J Immunol. 1992;148:3221-3229.
15. Arai T, Bhunia AK, Chatterjee S, Bulkley GB. Lactosylceramide stimulates human neutrophils to upregulate Mac-1, adhere to endothelium, and generate reactive oxygen metabolites in vitro. Circ Res. 1998;82:540-547.
16. Hinkovska-Galcheva VT, Boxer LA, Mansfield PJ, Harsh D, Blackwood A, Shayman JA. The formation of ceramide-1-phosphate during neutrophil phagocytosis and its role in liposome fusion. J Biol Chem. 1998;273:33203-33209.
17. Fantini J, Cook DG, Nathanson N, Spitalnik SL, Gonzalez-Scarano F. Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. Proc Natl Acad Sci U S A. 1993;90:2700-2704.
18. Brown KE, Anderson SM, Young NS. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science. 1993;262:114-117.
19. O'Brien AD, Holmes RK. Shiga and shiga-like toxins. Microbiol Rev. 1987;51:206-220.
20. LaCasse EC, Bray MR, Patterson B, et al. Shigalike toxin-1 receptor on human breast cancer, lymphoma, and myeloma and absence from CD34+ hematopoietic stem cells: implications for ex vivo tumor purging and autologous stem cell transplantation. Blood. 1999;94:2901-2910.
21. k antigen) and a novel platelet glycosphingolipid. Infect Immun. 1998;66:4355-4366.
22. LaCasse EC, Saleh MT, Patterson B, Minden MD, Gariepy J. Shiga-like toxin purges human lymphoma from bone marrow of severe combined immunodeficient mice. Blood. 1996;88:1561-1567.
23. Ariga T, Yoshida K, Nemoto K, Seki M, Miyatani N, Yu RK. Glycolipid changes in murine myelogenous leukemias: neutral glycolipids as markers for specific populations of leukemias. Biochemistry. 1991;30:7953-7961.
24. Kiguchi K, Henning-Chubb CB, Huberman E. Glycosphingolipid patterns of peripheral blood lymphocytes, monocytes, and granulocytes are cell specific. J Biochemistry. 1990;107:8-14.
25. Cooling LLW, Koerner TAW, Naides SJ. Multiple glycosphingolipids determine the tissue tropism of parvovirus B19. J Infect Dis. 1995;172:1198-1205.
26. Trinchieri G. The hematopoietic system and hematopoiesis. In: Knowles DM, ed. Neoplastic Hematopathology. Baltimore, MD: Williams and Wilkins; 1992:1-25.
27. Buehler J, Qwan E, DeGregorio MW, Macher BA. Biosynthesis of glycosphingolipids by human myeloid leukemia cells. Biochemistry. 1985;24:6978-6984.
28. Kannagi R, Papayannopoulou T, Nakamoto B, et al. Carbohydrate antigen profiles of human erythroleukemia cell lines HEL and K562. Blood. 1983;62:1230-1241.
29. Klock JC, Macher BA, Lee WMF. Complex carbohydrates as differentiation markers in malignant blood cells: glycolipids in the human leukemias. Blood Cells, 1981;7:247-255.
30. Klock JC, D'Angona JL, Macher BA. Chemical characterization of neutral glycolipids in the human myeloid leukemias. J Lipid Res. 1981;22:1079-1083.
31. Macher BA, Lee WMF, Westrick MA. Glycosphingolipids of normal and leukemic human leukocytes. Mol Cell Biochem. 1982;47:81-95.
32. Stults CLM, Larsen RD, Macher BA. α1,4 galactosyltransferase activity and Gb3Cer expression in human leukemia/lymphoma cell lines. Glycoconj J. 1995;12:680-689.
33. Kurtzman GJ, Ozawa K, Cohen B, Hanson G, Oseas R, Young NS. Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med. 1987;317:287-294.
34. McClain K, Estrov Z, Chen H, Mahoney DH. Chronic neutropenia of childhood: frequent association with parvovirus infection and correlation with bone marrow culture studies. Br J Haematol. 1993;85:57-62.
35. Potter CG, Potter AC, Hatton CSR, et al. Variation of erythroid and myeloid precursors in the marrow and peripheral blood of volunteer subjects infected with human parvovirus (B19). J Clin Invest. 1987;79:1486-1492.
36. Hanada T, Koike K, Takeya T, Nagasawa T, Matsunaga Y, Takita T. Human parvovirus B19-induced transient pancytopenia in a child with hereditary spherocytosis. Br J Haematol. 1988;70:113-115.
37. Fukuda MN, Dell A, Oates JE, Wu P, Klock JC, Fukuda M. Structures of glycosphingolipids isolated from human granulocytes. J Biol Chem. 1985;260:1067-1082.
38. Macher BA, Klock JC. Isolation and chemical characterization of neutral glycosphingolipids of human neutrophils. J Biol Chem. 1979;255:2092-2096.
39. Kalisiak A, Minniti G, Oosterwijk E, Old LJ, Scheinberg DA. Neutral glycosphingolipid expression in B-cell neoplasms. Int J Cancer. 1991;49:837-845.
40. Wiels J, Mangeney M, Tetaud C, Tursz T. Sequential shifts in the three major glycosphingolipid series are associated with B cell maturation. Int Immunol. 1991;3:1289-1300.
41. Taki T, Kawamoto M, Seto H, et al. Differentiationassociated changes of glycolipid composition and metabolism in mouse myeloid leukemia cells. Induction of globotriaosylceramide and α galactosyltransferase. J Biochem. 1983;94:633-644.
42. Hakomori SI. Differential reactivities of fetal and adult human erythrocytes to antisera against glycolipids of human erythrocytes. Vox Sang. 1969;16:478-485.
43. Wiels J, Holmes EH, Cochran N, Tursz T, Hakomori SI. Enzymatic and organizational difference in expression of a Burkitt lymphoma-associated antigen (globotriosylceramide) in Burkitt lymphoma and lymphoblastoid cell lines. J Biol Chem. 259;1984:14783-14787.
44. Shigeki S, Alving C. Inhibitory effects of gangliosides on immune reactions of antibodies to neutral glycolipids in liposomes. Biochim Biophys Acta. 1986;858:118-124.
45. Urdal DL, Hakomori S. Characterization of tumorassociated ganglio-N-triaosylceramide and the dependency of its exposure and antigenicity on the sialosyl residues of a second glycoconjugate. J Biol Chem. 1983;258:6869-6874.
46. Bennet JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med. 1985;103:626-629.
47. Strauss RG, Rohret PA, Randels MJ, Winegarden DC. Granulocyte collection. J Clin Apheresis. 1991;6:241-243.
48. Padley D, Strauss RG, Wieland M, Randels MJ. Concurrent comparison of the Cobe Spectra and Fenwal CS3000 for the collection of peripheral blood mononuclear cells for autologous peripheral stem cell transplantation. J Clin Apheresis. 1991;6:77-80.
49. Cooling LLW, Zhang D-S, Walker KW, Koerner TAW. Detection in human blood platelets of sialyl Lewis X gangliosides: potential ligands for CD62 and other selectins. Glycobiology. 1995;5:571-581.
50. Koerner TAW, Weinfeld HM, Bullard LSB, Williams LCJ. Antibodies against platelet-glycosphin-golipids: detection in serum by quantitative HPTLC-autoradiography and association with autoimmune and alloimmune processes. Blood. 1989;74:274-284.
51. Ledeen RW, Yu RK. Gangliosides: structure, isolation and analysis. Methods Enzymol. 1982;83:139-191.
52. Saito T, Hakomori S. Quantitative isolation of total glycosphingolipids from animal cells. J Lipid Res. 1971;12:257-259.
53. Brodin NT, Dahmen J, Nilsson B, et al. Monoclonal antibodies produced by immunization with neoglycoproteins containing Galα1→4Galβ1→4Glcβ-O and Galα1→4Galβ1→4GlcNAcβ-O residues: useful immunochemical and cytochemical reagents for blood group P antigens and a differentiation marker in Burkitt lymphoma and other B-cell malignancies. Int J Cancer. 1988;42:185-194.
54. Kannagi R, Cocharan NA, Ishigami F, et al. Stage-specific embryonic antigens (SSEA-3 and -4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells. EMBO J. 1983;2:2355-2361.
55. Young WW, Portoukalian J, Hakomori S. Two monoclonal anticarbohydrate antibodies directed to glycosphingolipids with a lacto-N-glycosyl type II chain. J Biol Chem. 1981;256:10967-10972.
56. Solomon FR, Higgins TJ. A monoclonal antibody with reactivity to asialo GM1 and murine natural killer cells. Mol Immunol. 1987;24:57-65.
57. Hu J, Stults CLM, Holmes EH, Macher BA. Structural characterization of intermediates in the biosynthetic pathway of neolacto glycosphingolipids: differential expression in human leukemia cells, Glycobiology. 1994;4:251-257.
58. Kajigaya S, Fujii H, Field A, et al. Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions. Proc Natl Acad Sci U S A. 1991;88:4646-4650.
59. Donohue-Rolfe A, Jacewicz M, Keusch GT. Isolation and characterization of functional shiga toxin subunits and renatured holotoxin. Mol Microbiol. 1989;3:1231-1236.
60. Buehler J, Macher BA. Glycosphingolipid immunostaining: detection of antibody binding with an avidin-biotin enzyme system. Anal Biochem. 1986;158:283-287.
61. Christie WW. Rapid separation and quantification of lipid classes by high performance liquid chromatography and mass (light-scattering) detection. J Lipid Res. 1985;26:507-512.
62. Dabrowski J, Hanfland P, Egge H. Structural analysis of glycosphingolipids by high resolution H nuclear magnetic resonance spectroscopy. Biochemistry. 1980;19:5652-5658.
63. Koerner TAW, Prestegard JH, Demou PC, Yu RK. High-resolution proton NMR studies of gangliosides. Use of homonuclear two-dimensional spinecho J-correlated spectroscopy for determination of residue composition and anomeric configurations. Biochemistry. 1983;22:2676-2687.
64. Koerner TAW, Prestegard JH, Yu RK. Ollgosaccharide structure by two-dimensional proton nuclear magnetic resonance spectroscopy. Methods Enzymol. 1987;138:38-59.
65. 1H NMR studies of a biosynthetic lacto-ganglio hybrid glycosphingolipid: confirmation of structure, interpretation of "anomalous" chemical shifts, and evidence for interresidue amide-amide hydrogen bonding. Biochemistry. 1992;31:1069-1080.
66. Lawson AM, Chai W, Cashmore GC, Stoll MS, Hounsell EF, Feizi T. High-sensitivity structural analyses of oligosaccharide probes (neoglycolipids) by liquid-secondary-ion mass spectrometry. Carbohydr Res. 1990;200:47-57.
67. Wiesner DA, Sweeley CC. Microscale analysis of glycosphingolipids by methanolysis, peracetylation, and gas chromatography. Anal Biochem. 1994;217:316-322.
68. Bruning JL, Kintz BL. Computational Handbook of Statistics. 3rd ed. Glenview, IL: Scott, Foresman and Company; 1987.
69. Karlsson A, Miller-Podraza H, Johansson P, Karlsson K-A, Dahlgren C, Teneberg S. Different glycosphingolipid composition in human neutrophil subcellular compartments. Glycoconj J. 2001;18:231-243.
70. Suzuki A, Karol RA, Kundu S, Marcus DM. Glycosphingolipids of K562 cells: a chemical and immunological analysis. Int J Cancer. 1981;28:271-276.
71. Yiu SCK, Lingwood CA. Polyisobutylmethacrylate modifies glycolipid binding specificity of verotoxin 1 in thin-layer chromatogram overlay procedures. Anal Biochem. 1992;202:188-192.
72. Symington FW, Hedges DL, Hakomori SI. Glycolipid antigens of human polymorphonuclear neutrophils and the inducible HL-60 myeloid leukemia line. J Immunol. 1985;134:2498-2506.
73. Nakahara K, Ohashi T, Oda T, et al. Asialo GM1 as a cell-surface marker detected in acute lymphoblastic leukemia. N Engl J Med. 1980;302:674-677.
74. Gasa S, Mitsuyama T, Makita A. Proton nuclear magnetic resonance of neutral and acidic glycosphingolipids. J Lipid Res. 1983;24:174-182.
75. Koerner TAW, Scarsdale JN, Prestegard JH, Yu RK. Structure determination of glycolipids using two dimensional proton NMR spectroscopy: globoside. J Carbohydr Chem. 1984;3:565-580.
76. Le Beau MM. The role of cytogenetics in the diagnosis and classification of hematopoietic neoplasms. In: Knowles DM, ed. Neoplastic Hematopathology. Baltimore, MD: Williams and Wilkins; 1992:299-321.
77. Kurtzman G, Ozawa K, Gascon P, Cohen B, Caras M, Young N. Viral DNA in circulating cells of patients acutely infected with B19 parvovirus [abstract]. Blood. 1986;68(suppl 1):55a.
78. McEver RP, Moore KL, Cummings RD. Leukocyte trafficking mediated by selectin-carbohydrate interactions. J Biol Chem. 1995;270:11025-11028.
79. Skacel PO, Edwards AJ, Harrison CT, Watkins WM. Enzymatic control of the expression of the X determinant (CD15) in human myeloid cells during maturation: the regulatory role of 6-sialyltransferase. Blood. 1991;78:1452-1460.
80. Liu AH, Li F, Zhong L, Gu JX, Chen HL. Alterations in glycosyltransferases during myeloid and monocytoid differentiation of HL-60 cells. Cell Biol Int. 1998;22:545-550.
81. Nojiri H, Takaku F, Tetsuka T, Motoyoshi K, Miura Y, Saito M. Characteristic expression of glycosphingolipid profiles in the bipotential cell differentiation of human promyelocytic leukemia cell line HL-60. Blood. 1984;64:534-541.
82. Nakamura M, Tsunoda A, Sakoe K, et al. Total metabolic flow of glycosphingolipid biosynthesis is regulated by UDP-GlcNAc:lactosylceramide β1→3N-acetylglucosaminyltransferase and CMP-NeuAc:lactosylceramide α2→3sialyltransferase in human hematopoietic cell line HL-60 during differentiation. J Biol Chem. 1992;267:23507-23514.
83. Kyogashima M, Uemura K-I, Taketomi T. Comparison of glycolipids in various human leukemia cells. Jpn J Cancer Res. 1987;78:1229-1237.
84. Zimmerman JW, Lindermuth J, Fish PA, Palace GP, Stevenson TT, DeMong DE. A novel carbohydrate-glycosphingolipid interaction between a β-(1-3)-glucan immunomodulator, PGG-glucan, and lactosylceramide of human leukocytes. J Biol Chem. 1998;273:22014-22020.
85. Hugosson S, Angstrom J, Olsson B-M, et al. Glycosphingolipid binding specificities of Neisseria meningitidis and Haemophilus influenzae: detection, isolation and characterization of a bindingactive glycosphingolipid from human oropharyngeal epithelium. J Biochem. 1998;124:1138-1152.
86. Bhunia AK, Arai T, Bulkley G, Chatterjee S. Lactosylceramide mediates tumor necrosis factor-αinduced intercellular adhesion molecule (ICAM-1) expression and the adhesion of neutrophil in human umbilical vein endothelial cells. J Biol Chem. 1998;273:34349-34357.
87. Yohe HC, Wallace PK, Berenson CS, Ye S, Reinhold BB, Reinhold VN. The major gangliosides of human peripheral blood monocytes/macrophages: absence of ganglio series structures. Glycobiology. 2001;11:831-841.
88. Goodman JL, Nelson CM, Klein MB, Hayes SF, Weston BW. Leukocyte infection by the granulocytic ehrlichiosis agent is linked to expression of a selectin ligand. J Clin Invest. 1999;103:407-412.
89. Cooling L, Zhang DS, Koerner TAW, Lewis X and sialyl Lewis X glycosphingolipids. Trends Glycosci Glycotechnol. 1997;9:191-209.
90. von dem Borne AEG, Bos MJE, Joustra-Maas N, van't Veer MB, Tromp JF, Tetteroo PAT. Murine monoclonal anti-P. In: Reinharz EL, Haynes BF, Nadler LM, Bernstein ID, eds. Leukocyte Typing II. Vol 3. New York, NY: Plenum; 1986:123-132.
91. 6-fold increased cell sensitivity to verocytotoxin. J Biol Chem. 2000;275:6246-6251.
92. Ramegowda B, Tesh VL. Differentiation-associated toxin receptor modulation, cytokine production and sensitivity to shiga-like toxins in human monocytic cell lines. Infect Immun. 1996;64:1173-1180.
93. Nakamura K, Hashimoto Y, Moriwaki K, Yamakawa T, Suzuki A. Genetic regulation of GM4(NeuAc) expression in mouse erythrocytes. J Biochem. 1990;107:3-7.
94. Muthing J. Neutral glycosphingolipids and gangliosides from spleen T lymphoblasts of genetically different inbred mouse strains. Glycoconj J. 1997;14:241-248.
95. Ozawa K, Kurtzman G, Young NS. Productive infection by B19 parvovirus of human erythroid bone marrow cells in vitro. Blood. 1987;70:384-391.
96. Srivastava A, Bruno E, Briddell R, et al. Parvovirus B19-induced perturbation of human megakaryocytopoiesis in vitro. Blood. 1990;76:1997-2004.
97. Asada M, Furakawa K, Kantor C, Gahmberg CG, Kobata A. Structural study of the sugar chains of human leukocyte cell adhesion molecules CD11/CD18. Biochemistry. 1991;30:1156-1571.
98. Steffensen R, Carlier K, Wiels J, et al. Cloningand expression of the histo-blood group Pk UDP-galactose: Ga1β-4G1cβ1-cer α1,4-galactosyltransferase. Molecular genetic basis of the p phenotype. J Biol Chem. 2000;275:16723-16729.
99. Okajima T, Nakamura Y, Uchikawa M, et al. Expression cloning of human globoside synthase cDNAs. J Biol Chem. 2000;275:40498-40503.